CoChat

Circulating CD14+HLA‐DR−/low myeloid‐derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery

Gao, Xing‐Hui, Tian, Lu, Wu, Jiong, Ma, Xiao‐Lu, Zhang, Chun‐Yan, Zhou, Yan, Sun, Yun‐Fan, Hu, Bo, Qiu, Shuang‐jian, Zhou, Jian, Fan, Jia, Guo, Wei, Yang, Xin‐Rong · 2017 · Hepatology Research
Cited by 73

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aim: Myeloid‐derived suppressor cells (MDSCs) play an important role in tumor progression. The aim of the present study was to investigate the prognostic value of MDSCs for early recurrence of hepatocellular carcinoma (HCC) in patients undergoing curative resection. Methods: Myeloid‐derived suppressor cells were measured by flow cytometry. The correlation between MDSCs and tumor recurrence was analyzed using a cohort of 183 patients who underwent curative resection between February 2014 and July 2015. Prognostic significance was further assessed using Kaplan–Meier survival estimates and log–rank tests. Results: In vivo, CD14+HLA‐DR−/low MDSCs inhibit T cell proliferation and secretion. The frequency of CD14+HLA‐DR−/low MDSCs was significantly higher in HCC patients (3.7 ± 5.3%, n = 183) than in chronic hepatitis patients (1.4 ± 0.6%, n = 25) and healthy controls (1.1 ± 0.5%, n = 50). High frequency of MDSCs was significantly correlated with recurrence (time to recurrence) (P < 0.001) and overall survival (P = 0.034). Patients with HCC in the high MDSC group were prone to more vascular invasion (P = 0.018) and high systemic immune‐inflammation index (SII) (P = 0.009) than those in the low MDSC group. Scatter‐plot analyses revealed a significant positive correlation between the SII level and the frequency of MDSCs (r = 0.188, P = 0.011). Patients with HCC with a high MDSC frequency and high SII level had significantly shorter time to recurrence (P < 0.001) and overall survival (P = 0.028) than those with a low MDSC frequency and low SII. Conclusions: An increased frequency of MDSCs was correlated with early recurrence and predicted the prognosis of patients with HCC undergoing curative resection. The HCC patients with high frequency of MDSCs should be provided more advanced management and frequent monitoring.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/hepr.12831

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 73

Metadata

Authors
Gao, X., Tian, L., Wu, J., Ma, X., Zhang, C., Zhou, Y., Sun, Y., Hu, B., Qiu, S., Zhou, J., Fan, J., Guo, W., & Yang, X.
Venue
Hepatology Research
Publisher
Wiley
Published
2017-02-08
Volume
47
Issue
10
Pages
1061-1071
ISSN
  • 1386-6346 (ISSN-L)
  • 1872-034X
OpenAlex
W2533358869
Cited by
73
References
3
FWCI
2.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating CD14+HLA‐DR−/low myeloid‐derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery. https://app.cochat.ai/papers/10.1111/hepr.12831
The paper
Gao, X., Tian, L., Wu, J., Ma, X., Zhang, C., Zhou, Y., Sun, Y., Hu, B., Qiu, S., Zhou, J., Fan, J., Guo, W., & Yang, X. (2017). Circulating CD14+HLA‐DR−/low myeloid‐derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery. Hepatology Research. https://doi.org/10.1111/hepr.12831

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.